Abstract
Various direct- and indirect-acting serotonin (5-HT) agonists serve as training drugs in tests of stimulus control of behavior; such agents include: 5-hydroxytryptophan, 5-methoxy-N,N-di- methyltryptamine, and fenfluramine. However, with the recent discovery of multiple populations of central 5-HT binding sites, the concept of site-selective serotonergic agents needs to be addressed. Certain 4-substituted 1-(2,5-dimethoxyphenyl)-2-aminopropanes such as DOM (4- methyl), DOB (4-bromo), and DOI (4-iodo) appear to be 5-HT2-selective agonists and serve as effective training drugs in rats. Stimulus generalization occurs among these agents regardless of which is used as the training drug, although stimulus generalization does not occur with 5-HT1A- selective agonists [e.g., 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DP AT)] or with 5-HT1B- selective agonists [e.g., 1-(3-trifluoromethylphenyl)piperazine (TFMPP)]. 8-OH DPAT and TFMPP also serve as training drugs; the 8-OH DPAT-stimulus generalizes to other 5-HT1A agonists, but not to 5-HT1B or 5-HT2 agonists, whereas the TFMPP-stimulus generalizes to other 5-HT1B agonists, but not to 5-HT1A or 5-HT2 agonists. Classical serotonin antagonists, most of which are rather selective for 5-HT2 sites, and 5-HT2-selective antagonists are able to block the stimulus effects of DOM, DOB, and DOI, but not those of 8-OH DPAT or TFMPP. The results of such studies reveal that, in rats, site-selective 5-HT agonists produce stimulus effects that are also selective; although generalization may occur with nonselective 5-HT agonists, animals trained to discriminate site-selective 5-HT agonists apparently do not recognize other 5-HT agonists that are selective for a different site. Animals trained to discriminate such agents from saline might be useful for the identification and/or investigation of novel site-selective agonists and antagonists (for example, the 8-OH DPAT-stimulus generalizes to members of a new class of anxiolytics that display high affinity for 5-HT1A binding sites), and might also aid in the overall understanding of central serotonergic mechanisms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Appel JB, White FJ, Kuhn DM (1978) The use of drugs as discriminative stimuli in behavioral pharmacodynamics. In: Colpaert FC, Rosecrans JA (eds) Stimulus properties of drugs: ten years of progress. Elsevier, Amsterdam, pp 7–27
Arvidsson LE, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H (1981) 8-Hydroxy-2-(di-w-propylamino)tetralin, a new centrally acting 5-hydroxy- tryptamine receptor agonist. J Med Chem 24:921–923
Arvidsson LE, Hacksell U, Johansson AM, Nilsson JLG, Lindberg P, Sanchez D, Wikstrom H, Svensson K, Hjorth S, Carlsson A (1984) 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine agonists. J Med Chem 27:45–51
Arvidsson LE, Hacksell U, Glennon RA (1986) Recent advances in central 5-hydroxytryptamine agonists and antagonists. In: Jucker E (ed) Progress in drug research (to be published)
Barrett RJ, Blackshear MA, Sanders-Bush E (1982) discriminative stimulus properties of L-5- hydroxytryptophan: behavioral evidence for multiple serotonin receptors. Psychopharmacology 76:29–35
Colpaert FC, Janssen PAJ (1983) A characterization of LSD-antagonist effects of pirenperone in the rat. Neuropharmacology 22:1001–1005
Colpaert FC, Niemegeers CJE, Janssen PAJ (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and pirenperone, a LSD antagonist. J Pharmacol Exp Ther 221:206–215
Cunningham KA, Callahan PM, Appel JB (1985 a) Differentiation between the stimulus effects of L-5-hydroxytryptophan and LSD. Eur J Pharmacol 108:179–186
Cunningham KA, Callahan PM, Appel JB (1985 b) Similarities in the stimulus effects of 8-hy- droxy-2-(di-/i-propylamino)tetralin (8-OH DP AT), buspirone, and TVX Q 7821: implications for understanding the actions of novel anxiolytics. Soc Neurosci Abstr 11:1106
Friedman R, Barrett RJ, Sanders-Bush E (1983) Additional evidence that L-5-hydroxytrypto- phan discrimination models a unique serotonin receptor. Psychopharmacology 80:209–213
Friedman RA, Barrett RJ, Sanders-Bush E (1984) Discriminative stimulus properties of qui-pazine: mediation by serotonin-2 binding sites. J Pharmacol Exp Ther 228:628–635
Friedman RL, Sanders-Bush E, Barrett RL (1985) Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol 106:191–193
Fuller RW, Mason NR (1979) Structure-activity relationships in the actions of 1-phenyl- piperazines on brain serotonin receptors. In: Haber B, Gabay S, Issidorides MR, Alivisatos SGA (eds) Serotonin: current aspects of neurochemistry and function. Plenum, New York, pp 359–368
Glennon RA (1985) Interaction of hallucinogenic agents with serotonin receptors. In: Dahlbom R, Nilsson JLG (eds) Medicinal chemistry. Swedish Pharmaceutical,. Stockholm, pp 116–129
Glennon RA (1986 a) Central serotonin binding sites. In: Williams M, Glennon RA, Timmermans P (eds) Receptor pharmacology and function. Dekker, New York (to be published)
Glennon RA (1986 b) Discriminative stimulus properties of the serotonergic agent l-(2,5-dimeth-oxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39:825–831
Glennon RA (1986 c) Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT). Pharmacol Biochem Behav 25:135–139
Glennon RA, Hauck AE (1985) Mechanistic studies on DOM as a discriminative stimulus. Pharmacol Biochem Behav 23:937–941
Glennon RA, McKenney JD (1985) Site-selective 5-HT agonists as discriminative stimuli. Pharmacologist 27:194
Glennon RA, Rosecrans J A (1981) Speculations on the mechanism of action of hallucinogenic indolealkylamines. Neurosci Biobehav Rev 5:197–207
Glennon RA, Rosecrans JA, Young R (1982) The use of the drug discrimination paradigm for studying hallucinogenic agents. A review. In: Colpaert FC, Rosecrans JA (ed) Drug discrimination: applications in CNS pharmacology. Elsevier, Amsterdam, pp 69–96
Glennon RA, Rosecrans JA, Young R (1983 a) Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents. Med Res Rev 3:289–340
Glennon RA, Young R, Rosecrans J A (1983 b) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol 91:189–196
Glennon RA, McKenney JD, Young R (1984 a) Discriminative stimulus properties of the serotonin agonist l-(trifluoromethylphenyl)piperazine (TFMPP). Life Sci 35:1475–1480
Glennon RA, Titeler M, McKenney JD (1984 b) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2502–2511
Glennon RA, Titeler M, Young R (1986 a) Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies. Psychopharmacol Bull 935–959
Glennon RA, McKenney JD, Lyon RA, Titeler M (1986 b) 5-HT1 and 5-HT2 binding characteristics of l-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J Med Chem 29:194–199
Goudie AJ (1977) Discriminative stimulus properties of fenfluramine in an operant task. An analysis of its cue function. Psychopharmacology 53:97–102
Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: [3H]PAT. Nature 305:140–142
Haenlein M, Caul WF, Barrett RJ, Michaelis RC (1983) Discrimination of serotonergic drugs is unaltered in rats prenatally exposed to ethanol. Neurobehav Toxicol Teratol 5:475–478
Leysen JE (1985) characterization of serotonin receptor binding sites. In: Green AR (ed) Neuropharmacology of serotonin. Oxford University Press, Oxford, pp 79–116
Lyon RA, Titeler M, McKenney JD, Magee PS, Glennon RA (1986 a) Synthesis and evaluation of phenyl- and benzoyl piperazines as potential serotonergic agents. J Med Chem 29:630–634
Lyon RA, Titeler M, Glennon RA (1986 b) Serotonin receptor selectivity of serotonergic drugs. Soc Neurosci Abstr (to be published)
McElroy JF, Feldman RS (1984) Discriminative stimulus properties of fenfluramine: evidence for serotonergic involvement. Psychopharmacology 83:172–178
McKenney JD, Glennon RA (1986) TFMPP may produce its stimulus effects via a 5-HT1B mechanism. Pharmacol Biochem Behav 24:43–47
Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-w-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151–153
Moser P, Redfern PH (1985) The discriminative stimulus properties of 5-HTP are mediated by the 5-HT1 receptor. Br J Pharmacol 84:70P
Nelson DL, Taylor EW (1986) Spiroxatrine: a selective serotonin 1A receptor antagonist. Eur J Pharmacol 124:207–208
Ortmann R (1985) The 5-HT syndrome and the drug discrimination paradigm in rats: applications in behavioral studies on the central 5-HT system. Pharmacopsychiatry 18:198–201
Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]5-hydroxytrypt-amine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226
Peroutka SJ (1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine-1A receptors. Biol Psychiatry 20:971–979
Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: differential binding of [3H]5-hy- droxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol 16:687–699
Shannon M, Battaglia G, Glennon RA, Titeler M (1984) 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen l-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur J Pharmacol 102:23–29
Silverman PB, Ho BT (1980) The discriminative stimulus properties of 2,5-dimethoxy-4-methyl- amphetamine (DOM): differentiation from amphetamine. Psychopharmacology 68:209–215
Spencer DG, Glaser T, Schuurman T, Traber J (1984) Behavioral and neurochemical correlates of pharmacology involving the 5-HT1 receptor. Soc Neurosci Abstr 10:1072
Titeler M, Herrick K, Lyon RA, McKenney JD, Glennon RA (1985) [3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors. Eur J Pharmacol 117:145–146
Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidel PR (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res 12:741–744
Tricklebank MD, Forler C, Middlemiss DN, Fozard JR (1985) Subtypes of the 5-HT receptor mediating the behavioral responses to 5-methoxy-jV,jV-dimethyltryptamine in the rat. Eur J Pharmacol 117:15–24
White FJ, Appel JB (1981) A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine. Psychopharmacology 73:110–115
White FJ, Appel JB (1982) Lysergic acid diethylamide and lisuride: differentiation of their neuropharmacological actions. Science 216:535–537
White FJ, Kuhn DM, Appel JB (1977) Discriminative stimulus properties of quipazine. Neuropharmacology 16:827–832
White FJ, Appel JB, Kuhn DM (1979) Discriminative stimulus properties of quipazine: direct serotonergic mediation. Neuropharmacology 18:143–151
Winter JC (1979) Quipazine-induced stimulus control in the rat. Psychopharmacology 60:265–269
Yamamoto T, Solomon RE, Woods JH (1983) Amphetamine, quipazine, and cyclazocine discrimination. Pharmacologist 25:199
Young R, Glennon RA, Rosencrans JA (1981) Discriminative stimulus properties of the hallucinogenic agent DOM. Commun Psychopharm 4:501–504
Young R, Rosecrans JA, Glennon RA (1983) Behavioral effects of 5-methoxy-N,N-dimethyl-tryptamine and dose-dependent antagonism by BC-105. Psychopharmacology 80:156–160
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Glennon, R.A. (1988). Site-Selective Serotonin Agonists as Discriminative Stimuli. In: Colpaert, F.C., Balster, R.L. (eds) Transduction Mechanisms of Drug Stimuli. Psychopharmacology Series, vol 4. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73223-2_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-73223-2_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73225-6
Online ISBN: 978-3-642-73223-2
eBook Packages: Springer Book Archive